These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7813558)

  • 21. Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret.
    Endo T; Minami M; Monma Y; Saito H; Takeuchi M
    J Toxicol Sci; 1990 Nov; 15(4):235-44. PubMed ID: 1707101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
    Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
    Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret.
    Rudd JA; Naylor RJ
    Neuropharmacology; 1994 Dec; 33(12):1607-8. PubMed ID: 7760983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret.
    Percie du Sert N; Rudd JA; Moss R; Andrews PL
    Neurosci Lett; 2009 Nov; 465(1):16-20. PubMed ID: 19733218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further studies of the antiemetic activity of granisetron against whole body X-irradiation or cisplatin-induced emesis in the ferret.
    Marr HE; Davey PT; Boyle EA; Blower PR
    Pharmacology; 1994 May; 48(5):283-92. PubMed ID: 8016189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret.
    Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT
    Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
    Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
    Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.
    Milano S; Blower P; Romain D; Grélot L
    J Pharmacol Exp Ther; 1995 Aug; 274(2):951-61. PubMed ID: 7636759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone.
    Rudd JA; Tse JY; Wai MK
    Eur J Pharmacol; 2000 Mar; 391(1-2):145-50. PubMed ID: 10720646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin-induced emesis in Suncus murinus.
    Mutoh M; Imanishi H; Torii Y; Tamura M; Saito H; Matsuki N
    Jpn J Pharmacol; 1992 Mar; 58(3):321-4. PubMed ID: 1513079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
    Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon.
    Tanihata S; Oda S; Nakai S; Uchiyama T
    Eur J Pharmacol; 2004 Jan; 484(2-3):311-21. PubMed ID: 14744618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vomiting induction by ipecac syrup in dogs and ferrets.
    Yamashita M; Yamashita M; Tanaka J; Chagi K; Takeda S; Kurihara T; Takeda Y; Fujii Y
    J Toxicol Sci; 1997 Dec; 22(5):409-12. PubMed ID: 9442450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-independent model of cisplatin-induced emesis in the ferret.
    Rudd JA; Cheng CH; Naylor RJ
    Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret.
    King AG; Sanger GJ
    Neurosci Lett; 2005 Mar; 376(1):5-8. PubMed ID: 15694264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret.
    Rudd JA; Naylor RJ
    Eur J Pharmacol; 1997 Mar; 322(1):79-82. PubMed ID: 9088874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.
    Thompson PI; Bingham S; Andrews PL; Patel N; Joel SP; Slevin ML
    Br J Pharmacol; 1992 May; 106(1):3-8. PubMed ID: 1324067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of 5-HT3 receptors and vagal afferents in copper sulfate- and cisplatin-induced emesis in monkeys.
    Fukui H; Yamamoto M; Sasaki S; Sato S
    Eur J Pharmacol; 1993 Nov; 249(1):13-8. PubMed ID: 8282015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computerized detection and analysis of cancer chemotherapy-induced emesis in a small animal model, musk shrew.
    Huang D; Meyers K; Henry S; De la Torre F; Horn CC
    J Neurosci Methods; 2011 Apr; 197(2):249-58. PubMed ID: 21392533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.